Axial Biotherapeutics Launches to Treat Patients with CNS Disorders by Harnessing The Gut Microbiome
November 30, 2016Axial Licenses a New Class of CNS Biotherapeutics from the Mazmanian Laboratory at The California Institute of Technology (Caltech)
More »
Esperion Therapeutics Announces Publication of Definitive Paper on Bempedoic Acid Mechanism of Action in Nature Communications
November 28, 2016The paper systematically outlines the experiments and analyses undertaken by Esperion and its collaborators to fully understand the mechanism of action for how bempedoic acid reduces LDL-C.
More »
Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH
September 20, 2016Acquisition Adds Global Rights to Highly Differentiated Compounds to Treat Multi-Factorial Elements of NASH
More »